Business ❯ Pharmaceuticals

Licensing Agreements

Drug Development Cancer Treatment Sanofi Obesity Medications Collaborations Market Strategy Cancer Drugs Arrowhead Pharmaceuticals Partnerships Collaboration Deals Oncology Product Development Patent Litigation

AstraZeneca Licenses Global Rights to Zegfrovy From Dizal

The deal gives AstraZeneca the commercial scale to broaden access to the EGFR exon 20 insertion drug while first-line approval reviews continue.

Bristol Myers and Hengrui Ink Up to $15.2 Billion Drug Discovery Alliance

Lilly Licenses MeiraGTx Eye Gene Therapy in Deal Worth Up to $475 Million

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion